Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
[Autonomic neuropathies].
Olfactory System and Demyelination.
Can HPV immunisation cause ADEM? Two case reports and literature review.
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Interview: Experiences targeting B cells for the treatment of multiple sclerosis.
Perceived stress in multiple sclerosis: the potential role of mindfulness in health and well-being.
Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.
Imaging resting state brain function in multiple sclerosis.
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis.
Treatment of multiple sclerosis in children and its challenges.
Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
[Microglia in pathophysiology of neuroimmunological disorders].
Acute lumbosacral transverse myelitis.
Anodal tDCS increases corticospinal output and projection strength in multiple sclerosis.
Pregnancy, sex and hormonal factors in multiple sclerosis.
Immunotherapy of Neuromyelitis Optica.
Glial progenitor cell-based treatment and modeling of neurological disease.
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy.
Acute demyelinating encephalomyelitis in a child following malaria.
Revisiting the management of fatigue in multiple sclerosis in the context of rehabilitation: a narrative review of current evidence.
Characterising aggressive multiple sclerosis.

Pages